标题
Hypoxia: The Cornerstone of Glioblastoma
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 22, Pages 12608
出版商
MDPI AG
发表日期
2021-11-30
DOI
10.3390/ijms222212608
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hypoxia and the phenomenon of immune exclusion
- (2021) Violena Pietrobon et al. Journal of Translational Medicine
- The Roles of HIF-1α in Radiosensitivity and Radiation-Induced Bystander Effects Under Hypoxia
- (2021) Jianghong Zhang et al. Frontiers in Cell and Developmental Biology
- The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia
- (2021) Xing-chen Ding et al. Journal of Hematology & Oncology
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
- (2020) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- The significance of exosomes in the development and treatment of hepatocellular carcinoma
- (2020) Xin Li et al. Molecular Cancer
- AnvirzelTMregulates cell death through inhibiting GSK-3 activity in human U87 glioma cells
- (2020) Sule Terzioglu-Usak et al. NEUROLOGICAL RESEARCH
- Mitochondrial MUL1 E3 ubiquitin ligase regulates Hypoxia Inducible Factor (HIF-1α) and metabolic reprogramming by modulating the UBXN7 cofactor protein
- (2020) Lucia Cilenti et al. Scientific Reports
- Phase Ib clinical trial of OKN-007 in recurrent malignant glioma.
- (2020) James D. Battiste et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
- (2020) Bhavesh K. Ahir et al. MOLECULAR NEUROBIOLOGY
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Hypoxia-Driven Immune Escape in the Tumor Microenvironment
- (2020) Alyssa Vito et al. Cells
- SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines
- (2020) Filippo Torrisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evidence for hypoxia increasing the tempo of evolution in glioblastoma
- (2020) David Robert Grimes et al. BRITISH JOURNAL OF CANCER
- Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
- (2020) Faiqa Mudassar et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
- (2020) Zhaowu Ma et al. SEMINARS IN CANCER BIOLOGY
- Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor
- (2020) Jaclyn J. Renfrow et al. Scientific Reports
- The Role of Hypoxia and SRC Tyrosine Kinase in Glioblastoma Invasiveness and Radioresistance
- (2020) Filippo Torrisi et al. Cancers
- Investigating Glioblastoma Response to Hypoxia
- (2020) Agathe L. Chédeville et al. Biomedicines
- Revisiting the Warburg effect: historical dogma versus current understanding
- (2020) Peter Vaupel et al. JOURNAL OF PHYSIOLOGY-LONDON
- The role of hypoxia‐inducible factor 1 in tumor immune evasion
- (2020) Li You et al. MEDICINAL RESEARCH REVIEWS
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism
- (2019) Ilias Mylonis et al. Cells
- HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
- (2019) Jason Miska et al. Cell Reports
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Small cell carcinoma of the urinary bladder: a Clinicopathologic and Immunohistochemical analysis of 81 cases
- (2018) Gang Wang et al. HUMAN PATHOLOGY
- The role of hypoxia-inducible factor-2 alpha in angiogenesis
- (2018) Christina Befani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma
- (2018) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- WHO 2016 Classification of gliomas
- (2018) P. Wesseling et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Bevacizumab and Glioblastoma
- (2018) Michelle M. Kim et al. CANCER JOURNAL
- PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
- (2018) Youbang Xie et al. Molecular Medicine Reports
- The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma
- (2018) Sihua Huang et al. ONCOLOGY REPORTS
- LBH589 Inhibits Glioblastoma Growth and Angiogenesis Through Suppression of HIF-1α Expression
- (2017) Zhi-Gang Yao et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
- (2017) Juan Manuel Sepúlveda-Sánchez et al. NEURO-ONCOLOGY
- Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
- (2017) Nicole Colwell et al. NEURO-ONCOLOGY
- The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth
- (2017) Hyun Seung Ban et al. Cell Death & Disease
- Crosstalk between M2 macrophages and glioma stem cells
- (2017) Leora M. Nusblat et al. CELLULAR ONCOLOGY
- The Role of Hypoxia in Glioblastoma Invasion
- (2017) Ana Monteiro et al. Cells
- Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1α.
- (2017) R. Tibes et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.
- (2017) M. P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment
- (2016) Jun-Hai Tang et al. EXPERIMENTAL CELL RESEARCH
- Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
- (2016) Gang Wang et al. ONCOLOGY REPORTS
- Glioblastoma, hypoxia and autophagy: a survival-prone ‘ménage-à-trois’
- (2016) Soha Jawhari et al. Cell Death & Disease
- A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma
- (2016) Nageatte Ibrahim et al. Cancer Medicine
- Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1αsignalling
- (2015) Bo Xu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
- (2015) H. Shen et al. MOLECULAR CANCER THERAPEUTICS
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Hypoxia-inducible factors in cancer stem cells and inflammation
- (2015) Gong Peng et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3
- (2015) Martyn A. Sharpe et al. Oncotarget
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- (2015) Agnieszka Zimna et al. Biomed Research International
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Cancer stem cells and radioresistance
- (2014) Kiera Rycaj et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1α Stability in an E3 Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner
- (2014) Shweta Joshi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma
- (2014) Carlos Afonso Clara et al. NEUROPATHOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation
- (2014) Karim Bensaad et al. Cell Reports
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization
- (2013) Qian Liu et al. CARCINOGENESIS
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- The expression of hypoxia-inducible factor-1 in primary brain tumors
- (2013) Joanna Reszec et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression
- (2013) Carrie R. Muh et al. JOURNAL OF NEURO-ONCOLOGY
- HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression
- (2013) WENNA CHEN et al. ONCOLOGY REPORTS
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1 Interaction with Cofactors p300/CBP
- (2012) S. Yin et al. CLINICAL CANCER RESEARCH
- Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma
- (2012) ARNULF MAYER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hypoxia-related molecules HIF-1α, CA9, and osteopontin
- (2012) O.P. Erpolat et al. STRAHLENTHERAPIE UND ONKOLOGIE
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
- (2011) Puja Sapra et al. ANGIOGENESIS
- Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion
- (2011) Seth B. Coffelt et al. JOURNAL OF IMMUNOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
- (2011) B. Raychaudhuri et al. NEURO-ONCOLOGY
- Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy
- (2011) Tilda Barliya et al. PLoS One
- The IGFR1 inhibitor NVP-AEW541 disrupts a pro-survival and pro-angiogenic IGF-STAT3-HIF1 pathway in human glioblastoma cells
- (2010) Marzia B. Gariboldi et al. BIOCHEMICAL PHARMACOLOGY
- Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
- (2010) E. Terzuoli et al. CANCER RESEARCH
- The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
- (2010) John M. Heddleston et al. CELL CYCLE
- Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres
- (2010) Olga Méndez et al. Molecular Cancer
- The expression and significance of HIF-1α and GLUT-3 in glioma
- (2009) Yang Liu et al. BRAIN RESEARCH
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Identification of a Novel Small Molecule HIF-1 Translation Inhibitor
- (2009) T. Narita et al. CLINICAL CANCER RESEARCH
- Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block
- (2009) M. Y. Koh et al. CLINICAL CANCER RESEARCH
- Development of HIF-1 inhibitors for cancer therapy
- (2009) Barbara Onnis et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1α Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
- (2009) Carol L. Nilsson et al. JOURNAL OF PROTEOME RESEARCH
- Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains
- (2009) G. Bellot et al. MOLECULAR AND CELLULAR BIOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover
- (2008) Gabriela Alexandru et al. CELL
- Expression of hypoxia inducible factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma
- (2008) Mehmet Yasar Kaynar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1
- (2008) M. Y. Koh et al. MOLECULAR CANCER THERAPEUTICS
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started